Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

GEVO vs LIN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
GEVO
Gevo, Inc.

Chemicals - Specialty

Basic MaterialsNASDAQ • US
Market Cap$493M
5Y Perf.+57.4%
LIN
Linde plc

Chemicals - Specialty

Basic MaterialsNASDAQ • GB
Market Cap$228.85B
5Y Perf.+144.1%

GEVO vs LIN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
GEVO logoGEVO
LIN logoLIN
IndustryChemicals - SpecialtyChemicals - Specialty
Market Cap$493M$228.85B
Revenue (TTM)$174M$34.66B
Net Income (TTM)$-11M$7.13B
Gross Margin23.4%46.0%
Operating Margin-4.6%28.8%
Forward P/E27.7x
Total Debt$168M$26.99B
Cash & Equiv.$1M$5.06B

GEVO vs LINLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

GEVO
LIN
StockMay 20May 26Return
Gevo, Inc. (GEVO)100157.4+57.4%
Linde plc (LIN)100244.1+144.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: GEVO vs LIN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: LIN leads in 4 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Gevo, Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
GEVO
Gevo, Inc.
The Growth Play

GEVO is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 8.5%, EPS growth 58.8%, 3Y rev CAGR 415.1%
  • Lower volatility, beta 1.64, Low D/E 35.6%, current ratio 1.82x
  • 8.5% revenue growth vs LIN's 3.0%
Best for: growth exposure and sleep-well-at-night
LIN
Linde plc
The Income Pick

LIN carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 6 yrs, beta 0.24, yield 1.2%
  • 375.2% 10Y total return vs GEVO's -98.6%
  • Beta 0.24, yield 1.2%, current ratio 0.88x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthGEVO logoGEVO8.5% revenue growth vs LIN's 3.0%
Quality / MarginsLIN logoLIN20.6% margin vs GEVO's -6.6%
Stability / SafetyLIN logoLINBeta 0.24 vs GEVO's 1.64
DividendsLIN logoLIN1.2% yield; 6-year raise streak; the other pay no meaningful dividend
Momentum (1Y)GEVO logoGEVO+88.0% vs LIN's +11.2%
Efficiency (ROA)LIN logoLIN8.3% ROA vs GEVO's -1.7%, ROIC 11.3% vs -2.8%

GEVO vs LIN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

GEVOGevo, Inc.
FY 2025
Ethanol
95.6%$105M
Hydrocarbon
4.4%$5M
LINLinde plc
FY 2025
Americas Segment
45.9%$15.2B
EMEA Segment
25.8%$8.5B
APAC Segment
20.1%$6.7B
Engineering Segment
8.2%$2.7B

GEVO vs LIN — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLLINLAGGINGGEVO

Income & Cash Flow (Last 12 Months)

LIN leads this category, winning 5 of 6 comparable metrics.

LIN is the larger business by revenue, generating $34.7B annually — 198.7x GEVO's $174M. LIN is the more profitable business, keeping 20.6% of every revenue dollar as net income compared to GEVO's -6.6%. On growth, GEVO holds the edge at +47.5% YoY revenue growth, suggesting stronger near-term business momentum.

MetricGEVO logoGEVOGevo, Inc.LIN logoLINLinde plc
RevenueTrailing 12 months$174M$34.7B
EBITDAEarnings before interest/tax$18M$12.1B
Net IncomeAfter-tax profit-$11M$7.1B
Free Cash FlowCash after capex-$35M$5.1B
Gross MarginGross profit ÷ Revenue+23.4%+46.0%
Operating MarginEBIT ÷ Revenue-4.6%+28.8%
Net MarginNet income ÷ Revenue-6.6%+20.6%
FCF MarginFCF ÷ Revenue-19.9%+14.7%
Rev. Growth (YoY)Latest quarter vs prior year+47.5%+8.2%
EPS Growth (YoY)Latest quarter vs prior year+3.8%+13.4%
LIN leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

GEVO leads this category, winning 3 of 4 comparable metrics.

On an enterprise value basis, LIN's 19.7x EV/EBITDA is more attractive than GEVO's 102.1x.

MetricGEVO logoGEVOGevo, Inc.LIN logoLINLinde plc
Market CapShares × price$493M$228.8B
Enterprise ValueMkt cap + debt − cash$659M$250.8B
Trailing P/EPrice ÷ TTM EPS-14.50x33.85x
Forward P/EPrice ÷ next-FY EPS est.27.67x
PEG RatioP/E ÷ EPS growth rate1.33x
EV / EBITDAEnterprise value multiple102.12x19.75x
Price / SalesMarket cap ÷ Revenue3.07x6.73x
Price / BookPrice ÷ Book value/share1.01x5.82x
Price / FCFMarket cap ÷ FCF44.97x
GEVO leads this category, winning 3 of 4 comparable metrics.

Profitability & Efficiency

LIN leads this category, winning 6 of 9 comparable metrics.

LIN delivers a 17.8% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-2 for GEVO. GEVO carries lower financial leverage with a 0.36x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIN's 0.68x. On the Piotroski fundamental quality scale (0–9), LIN scores 6/9 vs GEVO's 4/9, reflecting solid financial health.

MetricGEVO logoGEVOGevo, Inc.LIN logoLINLinde plc
ROE (TTM)Return on equity-2.4%+17.8%
ROA (TTM)Return on assets-1.7%+8.3%
ROICReturn on invested capital-2.8%+11.3%
ROCEReturn on capital employed-3.1%+13.0%
Piotroski ScoreFundamental quality 0–946
Debt / EquityFinancial leverage0.36x0.68x
Net DebtTotal debt minus cash$166M$21.9B
Cash & Equiv.Liquid assets$1M$5.1B
Total DebtShort + long-term debt$168M$27.0B
Interest CoverageEBIT ÷ Interest expense-0.04x34.52x
LIN leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

Evenly matched — GEVO and LIN each lead in 3 of 6 comparable metrics.

A $10,000 investment in LIN five years ago would be worth $17,394 today (with dividends reinvested), compared to $3,476 for GEVO. Over the past 12 months, GEVO leads with a +88.0% total return vs LIN's +11.2%. The 3-year compound annual growth rate (CAGR) favors GEVO at 18.2% vs LIN's 11.8% — a key indicator of consistent wealth creation.

MetricGEVO logoGEVOGevo, Inc.LIN logoLINLinde plc
YTD ReturnYear-to-date-1.5%+15.5%
1-Year ReturnPast 12 months+88.0%+11.2%
3-Year ReturnCumulative with dividends+65.0%+39.7%
5-Year ReturnCumulative with dividends-65.2%+73.9%
10-Year ReturnCumulative with dividends-98.6%+375.2%
CAGR (3Y)Annualised 3-year return+18.2%+11.8%
Evenly matched — GEVO and LIN each lead in 3 of 6 comparable metrics.

Risk & Volatility

LIN leads this category, winning 2 of 2 comparable metrics.

LIN is the less volatile stock with a 0.24 beta — it tends to amplify market swings less than GEVO's 1.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. LIN currently trades 94.7% from its 52-week high vs GEVO's 68.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricGEVO logoGEVOGevo, Inc.LIN logoLINLinde plc
Beta (5Y)Sensitivity to S&P 5001.64x0.24x
52-Week HighHighest price in past year$2.97$521.28
52-Week LowLowest price in past year$1.01$387.78
% of 52W HighCurrent price vs 52-week peak+68.4%+94.7%
RSI (14)Momentum oscillator 0–10053.551.7
Avg Volume (50D)Average daily shares traded4.5M2.3M
LIN leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates GEVO as "Buy" and LIN as "Buy". Consensus price targets imply 72.4% upside for GEVO (target: $4) vs 9.3% for LIN (target: $540). LIN is the only dividend payer here at 1.21% yield — a key consideration for income-focused portfolios.

MetricGEVO logoGEVOGevo, Inc.LIN logoLINLinde plc
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$3.50$539.71
# AnalystsCovering analysts1428
Dividend YieldAnnual dividend ÷ price+1.2%
Dividend StreakConsecutive years of raises6
Dividend / ShareAnnual DPS$6.00
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.0%
Insufficient data to determine a leader in this category.
Key Takeaway

LIN leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GEVO leads in 1 (Valuation Metrics). 1 tied.

Best OverallLinde plc (LIN)Leads 3 of 6 categories
Loading custom metrics...

GEVO vs LIN: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is GEVO or LIN a better buy right now?

For growth investors, Gevo, Inc.

(GEVO) is the stronger pick with 849. 3% revenue growth year-over-year, versus 3. 0% for Linde plc (LIN). Linde plc (LIN) offers the better valuation at 33. 8x trailing P/E (27. 7x forward), making it the more compelling value choice. Analysts rate Gevo, Inc. (GEVO) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — GEVO or LIN?

Over the past 5 years, Linde plc (LIN) delivered a total return of +73.

9%, compared to -65. 2% for Gevo, Inc. (GEVO). Over 10 years, the gap is even starker: LIN returned +375. 2% versus GEVO's -98. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — GEVO or LIN?

By beta (market sensitivity over 5 years), Linde plc (LIN) is the lower-risk stock at 0.

24β versus Gevo, Inc. 's 1. 64β — meaning GEVO is approximately 584% more volatile than LIN relative to the S&P 500. On balance sheet safety, Gevo, Inc. (GEVO) carries a lower debt/equity ratio of 36% versus 68% for Linde plc — giving it more financial flexibility in a downturn.

04

Which is growing faster — GEVO or LIN?

By revenue growth (latest reported year), Gevo, Inc.

(GEVO) is pulling ahead at 849. 3% versus 3. 0% for Linde plc (LIN). On earnings-per-share growth, the picture is similar: Gevo, Inc. grew EPS 58. 8% year-over-year, compared to 7. 1% for Linde plc. Over a 3-year CAGR, GEVO leads at 415. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — GEVO or LIN?

Linde plc (LIN) is the more profitable company, earning 20.

3% net margin versus -21. 1% for Gevo, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LIN leads at 26. 3% versus -11. 7% for GEVO. At the gross margin level — before operating expenses — LIN leads at 43. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is GEVO or LIN more undervalued right now?

Analyst consensus price targets imply the most upside for GEVO: 72.

4% to $3. 50.

07

Which pays a better dividend — GEVO or LIN?

In this comparison, LIN (1.

2% yield) pays a dividend. GEVO does not pay a meaningful dividend and should not be held primarily for income.

08

Is GEVO or LIN better for a retirement portfolio?

For long-horizon retirement investors, Linde plc (LIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

24), 1. 2% yield, +375. 2% 10Y return). Gevo, Inc. (GEVO) carries a higher beta of 1. 64 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LIN: +375. 2%, GEVO: -98. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between GEVO and LIN?

Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: GEVO is a small-cap high-growth stock; LIN is a large-cap quality compounder stock. LIN pays a dividend while GEVO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

GEVO

High-Growth Disruptor

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 23%
  • Gross Margin > 14%
Run This Screen
Stocks Like

LIN

Quality Mega-Cap Compounder

  • Sector: Basic Materials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 12%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform GEVO and LIN on the metrics below

Revenue Growth>
%
(GEVO: 47.5% · LIN: 8.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.